Lista de obras - Manuel Francisco Ugarte Gil

A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients

artículo científico publicado en 2018

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

scientific article published on 30 March 2020

Abatacept for the treatment of systemic lupus erythematosus.

artículo científico publicado en 2016

Access to an optimal treatment. Current situation

artículo científico publicado en 2015

Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort

artículo científico publicado en 2020

Applying the 2019 EULAR/ACR Lupus Criteria to Patients from the LUMINA Cohort

artículo científico publicado en 2020

Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective

artículo científico publicado en 2020

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

artículo científico publicado en 2021

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

artículo científico publicado en 2022

Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?

artículo científico publicado en 2013

Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients

artículo científico publicado en 2015

Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population

artículo científico publicado en 2014

Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort

artículo científico publicado en 2020

Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort

artículo científico publicado en 2019

Coronary and Aortic Involvement as Initial Manifestations of Possible Giant Cell Arteritis in a Patient Without Cardiovascular Comorbidities

artículo científico publicado en 2016

Correction to: Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort

scientific article published on 01 June 2019

Defining Quality of Rheumatologic Care: Peru

artículo científico publicado en 2017

Disease features and outcomes among US lupus patients of Hispanic origin and their Mestizo counterpart in Latina America

artículo científico publicado en 2014

Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary

artículo científico publicado en 2015

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

artículo científico publicado en 2021

Epidemiology of systemic lupus erythematosus.

artículo científico publicado en 2017

Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort

artículo científico publicado en 2020

Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions

artículo científico publicado en 2018

Factors associated with disease expression patterns in systemic lupus erythematosus patients: results from LUMINA (LXXVII), a multiethnic US cohort

artículo científico publicado en 2016

Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus.

artículo científico publicado en 2018

Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort.

artículo científico publicado en 2017

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort

scientific article published on 10 July 2019

Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

artículo científico publicado en 2015

Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist

scientific article published on 15 April 2020

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatolog

artículo científico publicado en 2018

Genetics and genomics in Peru: Clinical and research perspective

article

Genetics of ANCA-associated Vasculitides

artículo científico publicado en 2014

High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients.

artículo científico publicado en 2014

Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort

artículo científico publicado en 2018

Hypokalemic Paralysis: A Hidden Card of Several Autoimmune Diseases

artículo científico publicado en 2017

Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis?

artículo científico publicado en 2016

Interest on the internet for systemic lupus erythematosus: Analysis of Google Trends in Latin American countries

artículo científico publicado en 2021

Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al

artículo científico publicado en 2018

Lupus: the new epidemic

scientific article published on 12 July 2019

Measures of Fatigue in Patients With Rheumatic Diseases: A Critical Review

artículo científico publicado en 2020

Medical Scientific Publications From Latin America: A Commentary

artículo científico publicado en 2019

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

artículo científico publicado en 2021

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

artículo científico

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort

scientific article published on 01 March 2019

Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)

scientific article published on 01 December 2020

Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus.

artículo científico publicado en 2016

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

artículo científico publicado en 2017

Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort

scientific article published on 24 January 2019

Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients

artículo científico publicado en 2019

Remission or low disease activity as a target in systemic lupus erythematosus.

artículo científico publicado en 2018

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al

scientific article published on 05 August 2020

Serum uric acid is associated with damage in patients with systemic lupus erythematosus

scientific article published on 05 February 2020

Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.

artículo científico publicado en 2017

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

artículo científico publicado en 2020

Systemic lupus erythematosus: The search for the ideal biomarker

artículo científico publicado en 2020

Systemic lupus erythematosus: a therapeutic challenge for the XXI century

artículo científico

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.

artículo científico publicado en 2014

Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort.

artículo científico publicado en 2019

Treat to target in systemic lupus erythematosus: a commentary

artículo científico publicado en 2016

Lista de obras de Manuel Francisco Ugarte Gil

A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

Abatacept for the treatment of systemic lupus erythematosus.

Access to an optimal treatment. Current situation

Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort

Applying the 2019 EULAR/ACR Lupus Criteria to Patients from the LUMINA Cohort

Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?

Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients

Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population

Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort

Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort

Coronary and Aortic Involvement as Initial Manifestations of Possible Giant Cell Arteritis in a Patient Without Cardiovascular Comorbidities

Correction to: Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort

Defining Quality of Rheumatologic Care: Peru

Disease features and outcomes among US lupus patients of Hispanic origin and their Mestizo counterpart in Latina America

Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Epidemiology of systemic lupus erythematosus.

Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort

Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions

Factors associated with disease expression patterns in systemic lupus erythematosus patients: results from LUMINA (LXXVII), a multiethnic US cohort

Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus.

Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort.

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort

Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatolog

Genetics and genomics in Peru: Clinical and research perspective

Genetics of ANCA-associated Vasculitides

High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients.

Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort

Hypokalemic Paralysis: A Hidden Card of Several Autoimmune Diseases

Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis?

Interest on the internet for systemic lupus erythematosus: Analysis of Google Trends in Latin American countries

Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al

Lupus: the new epidemic

Measures of Fatigue in Patients With Rheumatic Diseases: A Critical Review

Medical Scientific Publications From Latin America: A Commentary

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort

Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)

Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus.

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort

Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients

Remission or low disease activity as a target in systemic lupus erythematosus.

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al

Serum uric acid is associated with damage in patients with systemic lupus erythematosus

Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

Systemic lupus erythematosus: The search for the ideal biomarker

Systemic lupus erythematosus: a therapeutic challenge for the XXI century

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.

Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort.

Treat to target in systemic lupus erythematosus: a commentary